Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that.
A follow-up question about Common supplements that I did not know to ask the first time.
The earlier thread answered what I asked. What I should have asked is below, and I think it is the one that matters.
The opening post and I disagree about the size of the effect, not about the direction.
Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance would suggest.
Common supplements sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
This follows post #4 rather than contradicting it.
The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather than filling the gap.
Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the conservative reading is the obvious one.
Having read the whole Common supplements thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one instead.
Small methodological point on Common supplements: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
No disagreement from me. Posting only so the question does not look ignored.
Where I part company with post #9, and it is a narrow parting.
What I would check first on Common supplements is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Adding the measurement that post #12 says would settle it.
Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is not supported.
That is what I would do. It may not be what is correct.
Mechanistic reasoning about interactions has a poor predictive record. It is a good way to generate a question and a bad way to answer one.
Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as one.
Anyone who has looked at this more carefully, please correct the record.
Answering the question post #14 raises rather than the one it answers.
Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.
That has held every time I have looked, which is not the same as always.
The arithmetic in post #17 is right; the assumption feeding it is the part to check.
Practical experience of Common supplements, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Timing separation is the standard mitigation where absorption rate is the concern, and the interval that matters depends on the other drug rather than on this one.
It is the sort of thing that seems obvious in retrospect and was not at the time.
Taking post #17 at face value and following it one step further.
Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist.
The evidence for this is thinner than the way I have phrased it suggests.
Confirming post #18 from a second method, which matters more than confirming it from a second person.
Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.
I am describing what is, rather than arguing for what should be.
I had written a reply contradicting post #20 and deleted it. Here is what survived.
I have three months of notes on Common supplements and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.
Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.
Anyone with a larger sample, please post it.
Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.
This is where my knowledge stops and I would rather mark the edge than blur it.
A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is usually worse rather than better.
Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people.